AFT Pharmaceuticals Limited (AFP.AX)
AUD 2.55
(-1.54%)
AUD 2.55
(-1.54%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 20.15 Million NZD | -39.49% |
| 2023 | 33.3 Million NZD | 2.25% |
| 2022 | 32.56 Million NZD | -16.51% |
| 2021 | 39 Million NZD | -5.05% |
| 2020 | 41.08 Million NZD | 17.94% |
| 2019 | 34.83 Million NZD | 45.85% |
| 2018 | 23.88 Million NZD | 217.56% |
| 2017 | 7.52 Million NZD | 204.61% |
| 2016 | -7.18 Million NZD | -144.82% |
| 2015 | 16.03 Million NZD | 34.84% |
| 2014 | 11.89 Million NZD | 3.8% |
| 2013 | 11.45 Million NZD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q4 | 20.15 Million NZD | -40.79% |
| 2024 Q2 | 34.03 Million NZD | 2.2% |
| 2024 FY | 20.15 Million NZD | -39.49% |
| 2023 Q2 | 31.99 Million NZD | -1.75% |
| 2023 FY | 33.3 Million NZD | 2.25% |
| 2023 Q4 | 33.3 Million NZD | 4.07% |
| 2022 FY | 32.56 Million NZD | -16.51% |
| 2022 Q4 | 32.56 Million NZD | -8.47% |
| 2022 Q2 | 35.58 Million NZD | -8.78% |
| 2021 FY | 39 Million NZD | -5.05% |
| 2021 Q2 | 37.72 Million NZD | -8.17% |
| 2021 Q4 | 39 Million NZD | 3.4% |
| 2020 FY | 41.08 Million NZD | 17.94% |
| 2020 Q2 | 42.13 Million NZD | 20.95% |
| 2020 Q4 | 41.08 Million NZD | -2.49% |
| 2019 Q4 | 34.83 Million NZD | 0.86% |
| 2019 FY | 34.83 Million NZD | 45.85% |
| 2019 Q2 | 34.53 Million NZD | 44.61% |
| 2018 Q4 | 23.88 Million NZD | 48.84% |
| 2018 FY | 23.88 Million NZD | 217.56% |
| 2018 Q2 | 16.04 Million NZD | 113.36% |
| 2017 FY | 7.52 Million NZD | 204.61% |
| 2017 Q2 | 5.98 Million NZD | 222.29% |
| 2017 Q4 | 7.52 Million NZD | 25.66% |
| 2016 FY | -7.18 Million NZD | -144.82% |
| 2016 Q4 | -4.89 Million NZD | -133.28% |
| 2016 Q2 | 14.7 Million NZD | -8.32% |
| 2015 FY | 16.03 Million NZD | 34.84% |
| 2015 Q4 | 16.03 Million NZD | 0.0% |
| 2014 FY | 11.89 Million NZD | 3.8% |
| 2013 FY | 11.45 Million NZD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Althea Group Holdings Limited | 641 Thousand AUD | -3043.526% |
| Cann Group Limited | 70.82 Million AUD | 71.55% |
| ECS Botanics Holdings Ltd | -2.13 Million AUD | 1044.402% |
| Ecofibre Limited | 18.75 Million AUD | -7.432% |
| Elixinol Wellness Limited | 554 Thousand AUD | -3537.184% |
| Hygrovest Limited | -189 Thousand AUD | 10761.376% |
| IDT Australia Limited | 3.96 Million AUD | -408.325% |
| Invion Limited | -783.52 Thousand AUD | 2671.708% |
| Little Green Pharma Ltd | -532.33 Thousand AUD | 3885.21% |
| Live Verdure Ltd | -1.08 Million AUD | 1964.463% |
| Medical Developments International Limited | -7.44 Million AUD | 370.506% |
| Vitura Health Limited | -6.02 Million AUD | 434.221% |
| Vita Life Sciences Limited | -24.24 Million AUD | 183.117% |